A Phase I Trial of the Combination of the Hedgehog Inhibitor, LDE225, With Etoposide and Cisplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Phase of Trial: Phase I
Latest Information Update: 23 Aug 2017
At a glance
- Drugs Sonidegib (Primary) ; Cisplatin; Etoposide
- Indications Small cell lung cancer
- Focus Adverse reactions
- 14 Aug 2017 Status changed from active, no longer recruiting to completed.
- 15 Feb 2017 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
- 15 Feb 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Apr 2018.